Jan Einhorn
Impact in
- Immunology top 0.5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Oncology top 1%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 5
- Cancer Treatment and Pharmacology 2
- Cancer survivorship and care 2
-
- Immunotherapy and Immune Responses 3
- Co-authors
- Donald E. White (8 shared papers)Suzanne L. Topalian (7 shared papers)Claudia A. Seipp (7 shared papers)Steven A. Rosenberg (7 shared papers)Douglas J. Schwartzentruber (6 shared papers)James Chih‐Hsin Yang (7 shared papers)Patrick Hwu (3 shared papers)Nicholas P. Restifo (4 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)JNCI Journal of the National Cancer Institute (3 papers)Nature Medicine (1 paper)The Journal of Immunology (1 paper)Cancer (1 paper)
- Partner nations
- United StatesAustraliaMalaysia
In The Last Decade
Jan Einhorn
12 papers receiving 3.0k citations
Jan Einhorn's Hit Papers
Peers
Comparison fields: 5 of 78
- Immunology 2.4k
- Oncology 1.7k
- Molecular Biology 1.1k
- Genetics 338
- Biotechnology 89
Countries citing papers authored by Jan Einhorn
This map shows the geographic impact of Jan Einhorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Einhorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Einhorn more than expected).
Fields of papers citing papers by Jan Einhorn
This network shows the impact of papers produced by Jan Einhorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Einhorn. The network helps show where Jan Einhorn may publish in the future.
Co-authors
The 25 scholars most cited alongside Jan Einhorn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma Hit paper breakdown → | 1998 | 1532 |
| 2 | Treatment of Patients With Metastatic Melanoma With Autologous Tumor-Infiltrating Lymphocytes and Interleukin 2 Hit paper breakdown → | 1994 | 828 |
| 3 | 1998 | 257 | |
| 4 | 1999 | 241 | |
| 5 | 1999 | 155 | |
| 6 | 1994 | 59 | |
| 7 | 1995 | 42 | |
| 8 | 1998 | 10 | |
| 9 | 2015 | 6 | |
| 10 | 2012 | 1 | |
| 11 | 2011 | 1 | |
| 12 | 1989 | 1 |
About Jan Einhorn
Jan Einhorn is a scholar working on Oncology, Immunology, Molecular Biology, Genetics and Epidemiology, having authored 12 papers that have together received 3.1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (3 papers), vaccines and immunoinformatics approaches (2 papers), Cancer Treatment and Pharmacology (2 papers), Cancer survivorship and care (2 papers), Multiple and Secondary Primary Cancers (1 paper), Virus-based gene therapy research (1 paper), Breast Cancer Treatment Studies (1 paper) and Estrogen and related hormone effects (1 paper). The work is most often cited by research in Immunology (2.4k citations), Oncology (1.7k citations), Molecular Biology (1.1k citations), Genetics (338 citations) and Biotechnology (89 citations). Jan Einhorn has collaborated with scholars based in United States, Australia and Malaysia. Frequent co-authors include Donald E. White, Suzanne L. Topalian, Claudia A. Seipp, Steven A. Rosenberg, Douglas J. Schwartzentruber, James Chih‐Hsin Yang, Patrick Hwu, Nicholas P. Restifo, Paul J. Spiess and Susan Schwarz. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute, Nature Medicine, The Journal of Immunology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.